Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208102 · ClinicalTrials.gov registry record
Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
A clinical trial, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- Completed
- Registry status
- 155
- Enrollment target
NCT02208102: Completed study, sponsored by Texas Cardiac Arrhythmia Research Foundation.
NCT02208102 is a clinical trial that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 155 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02208102 has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- COMPLETED
- Registry status
- 155 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome To evaluate the inflammatory activation following catheter ablation by measuring serum-biomarker levels 24-hours after the procedure and examine the predictive role in procedure success To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)
Primary Outcome
Patients will be monitored for arrhythmia recurrence for 1 year after the ablation procedure. At the end of the study, biomarker data will be analyzed to see any predictive association with AFib recurrence
Interventions
- PROCEDURE Radio-frequency catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-05 |
What the finished NCT02208102 record still lists
NCT02208102 is an observational study that tracks outcomes without assigning an intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Radio-frequency catheter ablation is the first listed.
NCT02208102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02208102 about?
NCT02208102 is a clinical study titled "Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation". The purpose of this study is to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome To evaluate the inflammatory activation following catheter ablation by measuring serum-biomarker levels 24-hours after the procedure and examine the predictiv...
What is the current status of trial NCT02208102?
This trial is currently completed. The enrollment target is 155 participants. The study started on 2014-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02208102?
The interventions under investigation include: Radio-frequency catheter ablation (PROCEDURE).
Who is sponsoring clinical trial NCT02208102?
This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia